image
Replimune Group, Inc. REPL
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 10.8
-5.26 %
$ 739 M
Market Cap
-3.39
P/E
BALANCE SHEET
488 M ASSETS
-24.57%
Growth Rates
1Year -24.57%
3Years -3.52%
5Years 25.88%
7Years 54.88%
10Years 0.00%
113 M LIABILITIES
24.00%
Growth Rates
1Year 24.00%
3Years 36.65%
5Years 47.04%
7Years 18.58%
10Years 0.00%
375 M EQUITY
-32.56%
Growth Rates
1Year -32.56%
3Years -9.11%
5Years 22.13%
7Years 65.86%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Replimune Group, Inc.
image
Current Assets 434 M
Cash & Short-Term Investments 421 M
Receivables 4.92 M
Other Current Assets 8.08 M
Non-Current Assets 54.1 M
Long-Term Investments 0
PP&E 52.4 M
Other Non-Current Assets 1.7 M
Current Liabilities 40.4 M
Accounts Payable 2.58 M
Short-Term Debt 7.76 M
Other Current Liabilities 30.1 M
Non-Current Liabilities 72.8 M
Long-Term Debt 72 M
Other Non-Current Liabilities 786 K

Balance Sheet

Millions
Mar-2024 Mar-2023 Mar-2022 Mar-2021 Mar-2020 Mar-2019 Mar-2018 Mar-2017
ASSETS
Cash & Cash Equivalents 74.5 146.6 105.9 182.5 59.5 25.7 17.6 20.6
Short Term Investments 346.2 436.8 289.7 293.8 109.1 109.1 44.0 0
Receivables 4.9 2.9 3.1 3.0 3.0 2.5 2.4 1.4
Inventory 0 0 0 0 0 0 0 0
Other Current Assets 8.1 6.3 3.3 4.5 1.8 3.7 0.8 0.4
Total Current Assets 433.7 592.6 404.0 483.7 174.3 141.0 64.7 22.4
PP&E 52.4 52.4 55.6 57.7 58.2 12.2 0.4 0.3
Intangible Assets 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0
Long Term Investments 0 1.6 1.6 1.6 1.6 1.2 78 K 75 K
Other Long Term Assets 1.7 0 0 0 0 0 0 0
Other Assets 0 0 0 0 0 0 0 0
Total Assets 487.7 646.6 461.2 543.1 234.1 154.3 65.2 22.8
LIABILITIES
Accounts Payable 2.6 5.4 3.7 2.4 3.4 7.1 2.0 0.3
Short Term Debt 7.8 3.8 7.3 6.9 6.6 0 0 0
Other Current Liabilities 30.1 24.7 9.8 5.3 1.9 2.8 3.2 1.7
Total Current Liabilities 40.4 33.8 20.8 14.5 11.9 9.9 5.2 2.0
Long Term Debt 72.0 57.0 29.2 29.8 38.5 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 0
Other Liabilities 0.8 0.5 0 0 0 6.6 88.1 32.3
Total Liabilities 113.2 91.3 50.0 44.4 50.4 16.5 93.2 34.3
EQUITY
Common Stock 61 K 57 K 47 K 47 K 37 K 32 K 5 K 5 K
Retained Earnings (701.3) (485.5) (311.2) (193.2) (112.3) (59.8) (28.9) (9.2)
Other Accumulative Comprehensive Income/Loss 4.9 5.7 (1.0) (0.4) (1.0) (1.1) (0.2) (2.5)
Total Equity 374.5 555.3 411.2 498.7 183.7 137.9 (28.1) (11.5)
Total Liabilities and Equity 487.7 646.6 461.2 543.1 234.1 154.3 65.2 22.8
SHARES OUTSTANDING
Common Shares Outstanding 66.6 58.2 52.2 46.2 34.3 23.2 30.8 21.5